{"id":796801,"date":"2024-12-23T09:41:34","date_gmt":"2024-12-23T14:41:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"modified":"2024-12-23T09:41:34","modified_gmt":"2024-12-23T14:41:34","slug":"tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","title":{"rendered":"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WARREN, N.J., Dec.  23, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9xvxe0HJkM1Ipk5-LVUxS8pD1wpjGvA6tz0rJfThQlRu2FLoAvYIXhyGPhTPRjmS50cRd5FLrTvWSNZZsXieJw==\" rel=\"nofollow\" target=\"_blank\">Tevogen Bio<\/a> (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Os_5ur8gDxv_kIj5LtvqD8fgJ1P2bXNLSesN40MtEfzYrnl5kqdR2J1V7qLnJK2g-gYFFjUYL3cOTFtxrgYuotWdCkzH967LOY5t4eTdbAs=\" rel=\"nofollow\" target=\"_blank\">TVGN<\/a>), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today the company will host an AI panel during the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The panel, titled &#8220;AI in Biopharma: Next Frontier of Medical Innovation,&#8221; will explore the transformative potential of artificial intelligence in the biopharma industry. Panelists will include Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare of Microsoft (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5JBsMeMGm5EpvrhsWjT6PFyRjY2In9z1PICaUwdGKX2vMxkAspzb8z7veoXlnLcR-G7_wpGDRo8S8Txki3dWKQWVvXbvhKMJ3QeZreFNrv0=\" rel=\"nofollow\" target=\"_blank\">MSFT<\/a>), Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Dr. Sean Tunis, Principal of Rubix Health.<\/p>\n<p>The discussion will highlight how AI-driven technologies can revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster quicker innovation, and significantly reduce operating costs. Attendees can expect insights into how Tevogen.AI is leveraging advanced AI capabilities to advance precision T cell therapies for infectious diseases, cancers, and neurological disorders.<\/p>\n<p>\n        <strong>Event Details<\/strong>\n      <\/p>\n<p>\n        <strong>Date:<\/strong><br \/>\n        <br \/>Monday, January 13, 2025<\/p>\n<p>\n        <strong>Location:<\/strong><br \/>\n        <br \/>Marines&#8217; Memorial Club &amp; Hotel, 609 Sutter St, San Francisco, CA 94102<\/p>\n<p>\n        <strong>Time (PST):<\/strong><br \/>\n        <br \/>2:00 PM \u2013 2:30 PM \u2013 AI in Biopharma: Next Frontier of Medical Innovation<br \/>2:30\u00a0PM \u2013 3:15 PM \u2013 Afternoon Coffee Break<br \/>3:15 PM \u2013 4:00 PM \u2013 Pioneering the Economics of Health: Balancing Access and Outcomes<br \/>4:00 PM \u2013 6:00 PM \u2013 Reception and Cocktails<\/p>\n<p>For inquiries regarding additional event details, please contact communications@tevogen.com.<\/p>\n<p>\n        <strong>About Tevogen Bio<\/strong>\n      <\/p>\n<p>Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature\u2019s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence.<\/p>\n<p>Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen\u2019s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Tevogen Bio Communications<br \/>T: 1 877 TEVOGEN, Ext 701 <br \/>Communications@Tevogen.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzE2MzgyMzAtMWQyOC00NTJkLTg4YmUtMGU4ZmM1NTUyNzhlLTEzMDE0Njc=\/tiny\/Tevogen-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today the company will host an AI panel during the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The panel, titled &#8220;AI in Biopharma: Next Frontier of Medical Innovation,&#8221; will explore the transformative potential of artificial intelligence in the biopharma industry. Panelists will include Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare of Microsoft (Nasdaq: MSFT), Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Dr. Sean Tunis, Principal of Rubix Health. The discussion will highlight how &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-796801","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tevogen Bio to Host Panel &quot;AI In Biopharma: Next Frontier of Medical Innovation&quot; During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevogen Bio to Host Panel &quot;AI In Biopharma: Next Frontier of Medical Innovation&quot; During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today the company will host an AI panel during the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The panel, titled &#8220;AI in Biopharma: Next Frontier of Medical Innovation,&#8221; will explore the transformative potential of artificial intelligence in the biopharma industry. Panelists will include Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare of Microsoft (Nasdaq: MSFT), Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Dr. Sean Tunis, Principal of Rubix Health. The discussion will highlight how &hellip; Continue reading &quot;Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-23T14:41:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference\",\"datePublished\":\"2024-12-23T14:41:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":436,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Tevogen Bio to Host Panel \\\"AI In Biopharma: Next Frontier of Medical Innovation\\\" During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\",\"datePublished\":\"2024-12-23T14:41:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tevogen Bio to Host Panel \"AI In Biopharma: Next Frontier of Medical Innovation\" During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tevogen Bio to Host Panel \"AI In Biopharma: Next Frontier of Medical Innovation\" During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) &#8212; Tevogen Bio (\u201cTevogen\u201d or \u201cTevogen Bio Holdings Inc.\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today the company will host an AI panel during the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The panel, titled &#8220;AI in Biopharma: Next Frontier of Medical Innovation,&#8221; will explore the transformative potential of artificial intelligence in the biopharma industry. Panelists will include Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare of Microsoft (Nasdaq: MSFT), Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Dr. Sean Tunis, Principal of Rubix Health. The discussion will highlight how &hellip; Continue reading \"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-23T14:41:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference","datePublished":"2024-12-23T14:41:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"},"wordCount":436,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/","name":"Tevogen Bio to Host Panel \"AI In Biopharma: Next Frontier of Medical Innovation\" During the 43rd Annual J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=","datePublished":"2024-12-23T14:41:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyMzM2NiM2NjY5MzI2IzIyODk5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tevogen Bio to Host Panel &#8220;AI In Biopharma: Next Frontier of Medical Innovation&#8221; During the 43rd Annual J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=796801"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/796801\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=796801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=796801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=796801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}